An insurance company shares a frightening data on increase in breast cancer

New Delhi: It is really an intimidating figure of breast cancer for Indian women. Religare Health Insurance has claimed breast cancer has jumped from 23% in 2014 to 38% in 2018 out of total cancer claims the insurance provider has received. It is really a huge jump and a waking call for women.

This report from insurance company comes hot on the heels of a report by CII that highlights that breast cancer is the most common type of cancer which afflicts women in India. As per the report, by 2026 we will witness rise in the breast cancer incidence to 35 per 100,000 women as compared to the present rate of 25.8.

The Lancet data reveals that the age standardized incidence rate of breast cancer in females has increased by 39.1% from 1990 to 2016 across the country, and the trend was observed in every state.

According to CII report cancer burden in India has more than doubled over the last 26 years, the highest increase amongst all therapy areas, with breast cancer being the most common among Indian women. The Breast Cancer Landscape in India, a white paper by the Confederation of Indian Industry (CII), which aims to provide insights regarding status and challenges in breast cancer care was released Thursday by Minister of State for Health Anupriya Patel.

As per the ICMR data, India had 14 lakh cancer patients in 2016 and this number is expected to increase. The government has laid down four priority cancers — breast cancer, cervical cancer, oral cancer and lung cancer which together constitute 41 per cent of cancer burden, the report mentioned.

Breast cancer is currently the most common cancer among Indian women, both in terms of incidence as well as mortality, with proportional prevalence in younger age-groups being higher than the global average.

Related Posts

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

Haryana Launches ‘Make in Haryana Industrial Policy’

Haryana Launches ‘Make in Haryana Industrial Policy’

A new pancreatic cancer pill may be a game changer for patients

A new pancreatic cancer pill may be a game changer for patients

NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

Industry asks NPPA to implement SOTS Scheme to resolve pending litigations

Industry asks NPPA to implement SOTS Scheme to resolve pending litigations